BAVA:VIE
Bavarian Nordic A/S
€29.48
arrow_downward
-0.61%(-0.18) 1H
7 Okt, 1:00:33 PTG GMT+2 · EUR
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk BAVA...
Buka
€29.62
Tinggi
€29.64
Rendah
€29.48
Permodalan Pasaran
2.59B
Purata volum
6.00
Volum
0.00
tgi 52 mgu
€32.47
rdh 52 mgu
€22.96
Bilangan pekerja
2K
Buka
€29.62
Tinggi
€29.64
Rendah
€29.48
Permodalan Pasaran
2.59B
Purata volum
6.00
Volum
0.00
tgi 52 mgu
€32.47
rdh 52 mgu
€22.96
Bilangan pekerja
2K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Invezz
·
15 jam lalu
S&P 500 catat rekod tertinggi ketika saham AI meningkat, hasil Perbendaharaan menurun
Chosunbiz
·
21 jam lalu
S&P 500 and Nasdaq set record as New York stocks open higher - CHOSUNBIZ
Invezz
·
1 hari lalu
Tinjauan Indeks Dow Jones: 4 Pemangkin Utama untuk Saham AS Minggu Ini
Profil
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination.
In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
Perihal Bavarian Nordic A/S